MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation

Dongjiu Li,1,* Chengyu Mao,1,* En Zhou,1,* Jiayin You,2,* Erhe Gao,3 Zhihua Han,1 Yuqi Fan,1 Qing He,1 Changqian Wang1 1Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China; 2Depa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li D, Mao C, Zhou E, You J, Gao E, Han Z, Fan Y, He Q, Wang C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/ffd65b152fb5408481c70cab87847ed1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ffd65b152fb5408481c70cab87847ed1
record_format dspace
spelling oai:doaj.org-article:ffd65b152fb5408481c70cab87847ed12021-12-02T13:02:37ZMicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation1178-7031https://doaj.org/article/ffd65b152fb5408481c70cab87847ed12020-11-01T00:00:00Zhttps://www.dovepress.com/microrna-21-mediates-a-positive-feedback-on-angiotensin-ii-induced-myo-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Dongjiu Li,1,* Chengyu Mao,1,* En Zhou,1,* Jiayin You,2,* Erhe Gao,3 Zhihua Han,1 Yuqi Fan,1 Qing He,1 Changqian Wang1 1Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China; 2Department of Emergency, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China; 3Center for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA*These authors contributed equally to this workCorrespondence: Changqian Wang Email wangcqdr17@163.comObjective: Post myocardial infarction (MI) fibrosis has been identified as an important factor in the progression of heart failure. Previous studies have revealed that microRNA-21 (miR-21) plays an important role in the pathogenesis of fibrosis. The purpose of this study was to explore the role of miR-21 in post-MI cardiac fibrosis.Material and Methods: MI was established in wild-type (WT) and miR-21 knockout (KO) mice. Primary mice cardiac fibroblasts (CFs) were isolated from WT and miR-21 KO mice and were treated with angiotensin II (Ang II) or Sprouty1 (Spry1) siRNA. Histological analysis and echocardiography were used to determine the extent of fibrosis and cardiac function.Results: Compared with WT mice, miR-21 KO mice displayed smaller fibrotic areas and decreased expression of fibrotic markers and inflammatory cytokines. In parallel, Ang II-induced myofibroblasts transformation was partially inhibited upon miR-21 KO in primary CFs. Mechanistically, we found that the expression of Spry1, a previously reported target of miR-21, was markedly increased in miR-21 KO mice post MI, further inhibiting ERK1/2 activation. In vitro studies showed that Ang II activated ERK1/2/TGF-β/Smad2/3 pathway. Phosphorylated Smad2/3 further enhanced the expression of α-SMA and FAP and may promote the maturation of miR-21, thereby downregulating Spry1. Additionally, these effects of miR-21 KO on fibrosis were reversed by siRNA-mediated knockdown of Spry1.Conclusion: Our findings suggest that miR-21 promotes post-MI fibrosis by targeting Spry1. Furthermore, it mediates a positive feedback on Ang II, thereby inducing the ERK/TGF-β/Smad pathway. Therefore, targeting the miR-21–Spry1 axis may be a promising therapeutic option for ameliorating post-MI cardiac fibrosis.Keywords: cardiac fibrosis, myocardial infarction, microRNA-21, Sprouty1, ERK/TGF-β/Smad signaling pathwayLi DMao CZhou EYou JGao EHan ZFan YHe QWang CDove Medical Pressarticlecardiac fibrosismyocardial infarctionmicrorna-21sprouty1erk/tgf-β/smad signaling pathwayPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 13, Pp 1007-1020 (2020)
institution DOAJ
collection DOAJ
language EN
topic cardiac fibrosis
myocardial infarction
microrna-21
sprouty1
erk/tgf-β/smad signaling pathway
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle cardiac fibrosis
myocardial infarction
microrna-21
sprouty1
erk/tgf-β/smad signaling pathway
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Li D
Mao C
Zhou E
You J
Gao E
Han Z
Fan Y
He Q
Wang C
MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation
description Dongjiu Li,1,* Chengyu Mao,1,* En Zhou,1,* Jiayin You,2,* Erhe Gao,3 Zhihua Han,1 Yuqi Fan,1 Qing He,1 Changqian Wang1 1Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China; 2Department of Emergency, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People’s Republic of China; 3Center for Translational Medicine, Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA*These authors contributed equally to this workCorrespondence: Changqian Wang Email wangcqdr17@163.comObjective: Post myocardial infarction (MI) fibrosis has been identified as an important factor in the progression of heart failure. Previous studies have revealed that microRNA-21 (miR-21) plays an important role in the pathogenesis of fibrosis. The purpose of this study was to explore the role of miR-21 in post-MI cardiac fibrosis.Material and Methods: MI was established in wild-type (WT) and miR-21 knockout (KO) mice. Primary mice cardiac fibroblasts (CFs) were isolated from WT and miR-21 KO mice and were treated with angiotensin II (Ang II) or Sprouty1 (Spry1) siRNA. Histological analysis and echocardiography were used to determine the extent of fibrosis and cardiac function.Results: Compared with WT mice, miR-21 KO mice displayed smaller fibrotic areas and decreased expression of fibrotic markers and inflammatory cytokines. In parallel, Ang II-induced myofibroblasts transformation was partially inhibited upon miR-21 KO in primary CFs. Mechanistically, we found that the expression of Spry1, a previously reported target of miR-21, was markedly increased in miR-21 KO mice post MI, further inhibiting ERK1/2 activation. In vitro studies showed that Ang II activated ERK1/2/TGF-β/Smad2/3 pathway. Phosphorylated Smad2/3 further enhanced the expression of α-SMA and FAP and may promote the maturation of miR-21, thereby downregulating Spry1. Additionally, these effects of miR-21 KO on fibrosis were reversed by siRNA-mediated knockdown of Spry1.Conclusion: Our findings suggest that miR-21 promotes post-MI fibrosis by targeting Spry1. Furthermore, it mediates a positive feedback on Ang II, thereby inducing the ERK/TGF-β/Smad pathway. Therefore, targeting the miR-21–Spry1 axis may be a promising therapeutic option for ameliorating post-MI cardiac fibrosis.Keywords: cardiac fibrosis, myocardial infarction, microRNA-21, Sprouty1, ERK/TGF-β/Smad signaling pathway
format article
author Li D
Mao C
Zhou E
You J
Gao E
Han Z
Fan Y
He Q
Wang C
author_facet Li D
Mao C
Zhou E
You J
Gao E
Han Z
Fan Y
He Q
Wang C
author_sort Li D
title MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation
title_short MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation
title_full MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation
title_fullStr MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation
title_full_unstemmed MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation
title_sort microrna-21 mediates a positive feedback on angiotensin ii-induced myofibroblast transformation
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/ffd65b152fb5408481c70cab87847ed1
work_keys_str_mv AT lid microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT maoc microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT zhoue microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT youj microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT gaoe microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT hanz microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT fany microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT heq microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
AT wangc microrna21mediatesapositivefeedbackonangiotensiniiinducedmyofibroblasttransformation
_version_ 1718393545144926208